APA (7th ed.) Citation

F, U., H, S., K, I., & T, K. (2024). Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer". International journal of urology : official journal of the Japanese Urological Association, 31(10), 1107. https://doi.org/10.1111/iju.15537

Chicago Style (17th ed.) Citation

F, Urabe, Suzuki H, Iwatani K, and Kimura T. "Editorial Comment on "Efficacy and Safety of Dose-dense Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer"." International Journal of Urology : Official Journal of the Japanese Urological Association 31, no. 10 (2024): 1107. https://doi.org/10.1111/iju.15537.

MLA (9th ed.) Citation

F, Urabe, et al. "Editorial Comment on "Efficacy and Safety of Dose-dense Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer"." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 31, no. 10, 2024, p. 1107, https://doi.org/10.1111/iju.15537.